# OnCo record azd4512 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/azd4512/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "azd4512" ;
  schema:name "AZD4512"@en ;
  schema:description "AZD4512 is an experimental antibody-drug conjugate from AstraZeneca in phase 2 trials for hodgkin lymphoma, aimed at CD22."@en ;
  schema:url <https://onco.cc/drugs/azd4512/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=AZD4512> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "ADC" ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/> ;
  onco:targets <https://onco.cc/targets/cd22/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> ;
  onco:trials <https://onco.cc/trials/nct07123454/>, <https://onco.cc/trials/nct07109219/> .